Capital Equity Investments L.p. Aeris is 10% at Adamas Pharmaceuticals Inc (ADMS). They have made 7 open-market trades across 1 company since 2014, most recently 2015-03-13.
CIK 0001605431
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ADMS | 1,662,128 | $13.7M |
Shares reported on the most recent Form 4, priced at the 2015-03-17 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 0% | 0% |
| Avg Move | -13.8% | +0.8% | +0.8% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADMS | SELL | 2015-03-13 | 2015-03-17 | $17.23 | $6.0M | -13.8% | +0.8% | +0.8% |
| ADMS | SELL | 2014-12-02 | 2014-12-04 | $14.51 | $1.6M | -13.8% | +0.8% | +0.8% |
| ADMS | SELL | 2014-11-28 | 2014-12-02 | $14.53 | $198K | -13.8% | +0.8% | +0.8% |
| ADMS | SELL | 2014-11-26 | 2014-11-28 | $14.77 | $185K | -13.8% | +0.8% | +0.8% |
| ADMS | SELL | 2014-11-24 | 2014-11-26 | $14.85 | $149K | -13.8% | +0.8% | +0.8% |
| ADMS | SELL | 2014-11-21 | 2014-11-25 | $14.82 | $130K | -13.8% | +0.8% | +0.8% |
| ADMS | SELL | 2014-11-20 | 2014-11-24 | $14.69 | $51K | -13.8% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.